Should I buy Becton Dickinson (BDX) stock or is it too late?

Becton Dickinson · Health Care · price $188

See the full Becton Dickinson (BDX) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Citigroup — 66% of its targets hit on this sector (508 calls tested). It aims for $204 (+8.4 %), call made on August 8, 2026, maturing on August 8, 2027 (20 d ago).

The 5 reliable analysts $182-3.3 %

The 4 other firms $185-1.7 %

How to read it: the 5 reliable firms are not filtered by optimism — 2 aim above the price, 3 below, hence their $182 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Becton Dickinson

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Wells Fargo	57 %	+4.5 %	7	$170 -10%
Citigroup	62 %	+2.3 %	8	$204 +8%
Morgan Stanley	43 %	+1.1 %	14	$165 -12%
Raymond James	38 %	-0.8 %	16	$212 +13%
Stifel	57 %	-1.0 %	7	$169 -10%
Evercore ISI Group	20 %	-4.2 %	5	$180 -4%
Piper Sandler	14 %	-6.0 %	7	$175 -7%
JP Morgan	57 %	-6.7 %	7	$175 -7%

In short — Should you invest in Becton Dickinson? Is it too late, still worth it? Analysts are fairly positive (56% buy, median target $182, i.e. -3%), and the most reliable on BDX targets even higher. But the valuation is stretched (P/E ~33). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on BDX, Jefferies (100% hit rate, 3 scored calls), targets $190 (call made on February 10, 2026, maturing on February 10, 2027) (+1%) in its most recent call.
Pays a dividend (2.5% yield), raised for 28 years — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 9 ratings, 4 are neutral.
Limited upside: the median target is only -3% from the current price.
High valuation (P/E ~33): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on BDX

Median target $182 (-3%) · 9 ratings · Buy consensus

Strong Buy00%

Buy556%

Hold444%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Becton Dickinson now?

We won't decide for you. The facts: 56% of analysts rate it a buy, median target $182 (-3%), and Jefferies (most reliable on BDX, 100%) targets $190. Weigh that against valuation (P/E ~33). This is not personalized advice.

Is it too late to invest in Becton Dickinson?

The stated upside is small: the median target ($182) sits just -3% from the price ($188) (most reliable on BDX: Jefferies, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Becton Dickinson still worth investing in?

It depends on the gap between the price ($188) and its estimated value: analysts target $182 on median (-3%), with 56% buys (most reliable on BDX: Jefferies, 100%). Cross-check with their real reliability on BDX and the cautions above. Information, not advice.

What's the main risk in buying BDX?

The consensus is not unanimous: of 9 ratings, 4 are neutral.

→ Go deeper: the full Becton Dickinson profile (consensus, analyst reliability, price target, performance).